State of Alaska Department of Revenue Purchases 1,170 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

State of Alaska Department of Revenue grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,789 shares of the medical equipment provider’s stock after acquiring an additional 1,170 shares during the period. State of Alaska Department of Revenue’s holdings in Intuitive Surgical were worth $20,696,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.3%

Shares of ISRG stock opened at $512.11 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The firm has a market capitalization of $183.55 billion, a price-to-earnings ratio of 75.09, a price-to-earnings-growth ratio of 5.51 and a beta of 1.67. The firm has a fifty day moving average of $527.58 and a 200-day moving average of $538.12.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the business’s stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now directly owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of research reports. Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. Finally, Piper Sandler lowered their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.